Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD, 20850, USA.
Department of Family Medicine and Public Health Sciences, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Cancer Causes Control. 2020 Jan;31(1):85-93. doi: 10.1007/s10552-019-01248-1. Epub 2019 Nov 28.
Renal cell carcinoma (RCC) incidence is higher among black than white Americans. The reasons for this disparity remain unclear.
We calculated race- and sex-specific population attributable risk percentages (PAR%) and their 95% confidence intervals (CI) for hypertension and chronic kidney disease (CKD) among black and white subjects ≥ 50 years of age from the US Kidney Cancer Study (USKC; 965 cases, 953 controls), a case-control study in Chicago and Detroit, and a nested case-control study in the Kaiser Permanente Northern California health care network (KPNC; 2,162 cases, 21,484 controls). We also estimated PAR% for other modifiable RCC risk factors (cigarette smoking, obesity) in USKC.
In USKC, the PAR% for hypertension was 50% (95% CI 24-77%) and 44% (95% CI 25-64%) among black women and men, respectively, and 29% (95% CI 13-44%) and 27% (95% CI 14-39%) for white women and men, respectively. In KPNC, the hypertension PAR% was 40% (95% CI 18-62%) and 23% (95% CI 2-44%) among black women and men, and 27% (95% CI 20-35%) and 19% (95% CI 14-24%) among white women and men, respectively. The PAR% for CKD in both studies ranged from 7 to 10% for black women and men but was negligible (<1%) for white subjects. In USKC, the PAR% for current smoking was 20% and 8% among black and white men, respectively, and negligible and 8.6% for black and white women, respectively. The obesity PAR% ranged from 12 to 24% across all race/sex strata.
If the associations found are causal, interventions that prevent hypertension and CKD among black Americans could potentially eliminate the racial disparity in RCC incidence (hypothetical black:white RCC incidence ratio of 0.5).
与白种美国人相比,黑种美国人的肾细胞癌(RCC)发病率更高。造成这种差异的原因尚不清楚。
我们计算了美国肾脏癌研究(USKC;965 例病例,953 例对照)、芝加哥和底特律病例对照研究以及 Kaiser Permanente 北加州医疗保健网络(KPNC;2162 例病例,21484 例对照)中年龄≥50 岁的黑人和白人患者中高血压和慢性肾脏病(CKD)的种族和性别特异性人群归因风险百分比(PAR%)及其 95%置信区间(CI)。我们还估计了 USKC 中其他可改变的 RCC 风险因素(吸烟、肥胖)的 PAR%。
在 USKC 中,黑人女性和男性的高血压 PAR%分别为 50%(95%CI 24-77%)和 44%(95%CI 25-64%),而白人女性和男性的高血压 PAR%分别为 29%(95%CI 13-44%)和 27%(95%CI 14-39%)。在 KPNC 中,黑人女性和男性的高血压 PAR%分别为 40%(95%CI 18-62%)和 23%(95%CI 2-44%),而白人女性和男性的高血压 PAR%分别为 27%(95%CI 20-35%)和 19%(95%CI 14-24%)。在这两项研究中,黑人和白人女性和男性的 CKD PAR%均为 7%至 10%,而白人受试者则微不足道(<1%)。在 USKC 中,黑人和白人男性的当前吸烟 PAR%分别为 20%和 8%,而黑人和白人女性的吸烟 PAR%分别为微不足道和 8.6%。肥胖的 PAR%在所有种族/性别群体中范围从 12%到 24%。
如果发现的关联是因果关系,那么预防黑种美国人高血压和 CKD 的干预措施可能会消除 RCC 发病率的种族差异(假设黑种与白种美国人的 RCC 发病率比为 0.5)。